Literature DB >> 11641327

Chemiluminescent measurements of nitric oxide pulmonary diffusing capacity and alveolar production in humans.

I B Perillo1, R W Hyde, A J Olszowka, A P Pietropaoli, L M Frasier, A Torres, P T Perkins, R E Forster, M J Utell, M W Frampton.   

Abstract

Measurements of nitric oxide (NO) pulmonary diffusing capacity (DL(NO)) multiplied by alveolar NO partial pressure (PA(NO)) provide values for alveolar NO production (VA(NO)). We evaluated applying a rapidly responding chemiluminescent NO analyzer to measure DL(NO) during a single, constant exhalation (Dex(NO)) or by rebreathing (Drb(NO)). With the use of an initial inspiration of 5-10 parts/million of NO with a correction for the measured NO back pressure, Dex(NO) in nine healthy subjects equaled 125 +/- 29 (SD) ml x min(-1) x mmHg(-1) and Drb(NO) equaled 122 +/- 26 ml x min(-1) x mmHg(-1). These values were 4.7 +/- 0.6 and 4.6 +/- 0.6 times greater, respectively, than the subject's single-breath carbon monoxide diffusing capacity (Dsb(CO)). Coefficients of variation were similar to previously reported breath-holding, single-breath measurements of Dsb(CO). PA(NO) measured in seven of the subjects equaled 1.8 +/- 0.7 mmHg x 10(-6) and resulted in VA(NO) of 0.21 +/- 0.06 microl/min using Dex(NO) and 0.20 +/- 0.6 microl/min with Drb(NO). Dex(NO) remained constant at end-expiratory oxygen tensions varied from 42 to 682 Torr. Decreases in lung volume resulted in falls of Dex(NO) and Drb(NO) similar to the reported effect of volume changes on Dsb(CO). These data show that rapidly responding chemiluminescent NO analyzers provide reproducible measurements of DL(NO) using single exhalations or rebreathing suitable for measuring VA(NO).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641327     DOI: 10.1152/jappl.2001.91.5.1931

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  5 in total

1.  Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Zeling Cao; Stephen C Mathai; Laura K Hummers; Ami A Shah; Fredrick M Wigley; Noah Lechtzin; Paul M Hassoun; Reda E Girgis
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Long-term post-pneumonectomy pulmonary adaptation following all-trans-retinoic acid supplementation.

Authors:  Priya Ravikumar; D Merrill Dane; Paul McDonough; Cuneyt Yilmaz; Aaron S Estrera; Connie C W Hsia
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

3.  Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide.

Authors:  Connie W H Woo; Filly Cheung; Vincent W H Chan; Yaw L Siow; Karmin O
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

4.  Quantifying proximal and distal sources of NO in asthma using a multicompartment model.

Authors:  David A Shelley; James L Puckett; Steven C George
Journal:  J Appl Physiol (1985)       Date:  2010-01-21

5.  Airway and alveolar nitric oxide production, lung function, and pulmonary blood flow in sickle cell disease.

Authors:  Alan Lunt; Na'eem Ahmed; Gerrard F Rafferty; Moira Dick; David Rees; Sue Height; Swee Lay Thein; Anne Greenough
Journal:  Pediatr Res       Date:  2015-10-22       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.